Gruber U F
Postgrad Med J. 1969 Aug;45(526):534-8. doi: 10.1136/pgmj.45.526.534.
Volume replacement is the most important step in treating hypovolaemic shock. Blood is needed when the oxygen carrying capacity threatens to fall below a critical level, but has the disadvantage of transmitting virus hepatitis. Anicteric hepatitis is about four times more frequent than the icteric form. Pasteurized plasma protein solution and albumin are free from the risk of transmitting hepatitis virus, and are good volume restorers. Dextran 70 represents the best artificial colloid with additional anti-thrombotic properties. Dextran 40 is indicated in special situations to promote flow. There is no proof that large amounts of Ringer solution are superior for treating hypovolaemic shock in man compared with colloids and electrolytes.
补充血容量是治疗低血容量性休克最重要的步骤。当携氧能力有可能降至临界水平以下时需要输血,但输血有传播病毒性肝炎的缺点。无黄疸型肝炎的发病率约为黄疸型肝炎的四倍。经巴氏消毒的血浆蛋白溶液和白蛋白没有传播肝炎病毒的风险,是良好的血容量扩充剂。右旋糖酐70是具有额外抗血栓特性的最佳人工胶体。右旋糖酐40在特殊情况下用于促进血流。没有证据表明,与胶体和电解质相比,大量林格氏液在治疗人类低血容量性休克方面更具优势。